- Home
- AQST vs ACB Comparison
AQST vs ACB Comparison
Compare AQST & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- ACB
- Stock Information
- Founded
- AQST 2004
- ACB 2013
- Country
- AQST United States
- ACB Canada
- Employees
- AQST N/A
- ACB N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- ACB Pharmaceuticals and Biotechnology
- Sector
- AQST Health Care
- ACB Health Care
- Exchange
- AQST Nasdaq
- ACB Nasdaq
- Market Cap
- AQST 254.1M
- ACB 234.9M
- IPO Year
- AQST 2018
- ACB N/A
- Fundamental
- Price
- AQST $2.79
- ACB $4.85
- Analyst Decision
- AQST Strong Buy
- ACB Hold
- Analyst Count
- AQST 5
- ACB 1
- Target Price
- AQST $11.40
- ACB N/A
- AVG Volume (30 Days)
- AQST 939.1K
- ACB 958.7K
- Earning Date
- AQST 05-12-2025
- ACB 06-20-2025
- Dividend Yield
- AQST N/A
- ACB N/A
- EPS Growth
- AQST N/A
- ACB N/A
- EPS
- AQST N/A
- ACB 0.07
- Revenue
- AQST $57,561,000.00
- ACB $222,964,332.00
- Revenue This Year
- AQST N/A
- ACB $27.84
- Revenue Next Year
- AQST $39.51
- ACB $11.50
- P/E Ratio
- AQST N/A
- ACB $73.79
- Revenue Growth
- AQST 13.79
- ACB 20.72
- 52 Week Low
- AQST $2.20
- ACB $3.42
- 52 Week High
- AQST $5.80
- ACB $8.14
- Technical
- Relative Strength Index (RSI)
- AQST 49.93
- ACB 58.95
- Support Level
- AQST $2.59
- ACB $4.54
- Resistance Level
- AQST $3.05
- ACB $4.92
- Average True Range (ATR)
- AQST 0.16
- ACB 0.23
- MACD
- AQST 0.00
- ACB 0.03
- Stochastic Oscillator
- AQST 43.57
- ACB 81.20
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About ACB Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.